Navigation Links
Transplantation: 'molecular miscegenation' blurs the boundary between self and non-self
Date:10/30/2008

A new discovery by London biologists may yield new ways of handling the problem of transplant rejection. In a research article published in the November 2008 print issue of The FASEB Journal (http://www.fasebj.org), the scientists confirm the two-way transfer of a molecule (called "MHC") that instructs the immune system to tell "self" from "non-self." By disrupting the transfer of this molecule, newly transplanted organs should become "invisible" to the host's immune system. Such an advance would be considered a major medical breakthrough because current methods of preventing organ rejection involve weakening the host's immune system, which can lead to life-threatening infections.

"The medical potential of this finding is enormous," says Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal, "Understanding molecular miscegenation should not only make transplantation more widespread and effective, but also shed light on how microbes disrupt our body's immune apparatus for distinguishing self from non-self."

The researchers made this discovery when they transplanted kidneys or hearts from one set of mice into another, with each set of mice having a different version of the molecule being studied. The researchers then conducted tests to see if the molecules were transferred. In the recipient mice, the donated kidneys or hearts and the host tissue expressed both types of molecules. This is the first time that this transfer has been shown to happen in a living system.

Wilson Wong, senior researcher on the study from King's College London, states that although the findings are tantalizing, they represent only a very primitive understanding of this phenomenon. Nevertheless, he hopes "that this study will lead to a better understanding of the immune system to benefit the development of new therapies in areas related to transplantation."


'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related medicine news :

1. A new molecular zip code, and a new drug target for Huntingtons disease
2. New knock-out gene model provides molecular clues to breast cancer
3. Molecular probe paints cancer cells in living animals, Stanford researchers find
4. Story ideas from molecular & cellular proteomics
5. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
8. Molecular profiling can accurately predict survival in colon cancer patients
9. Xceed Molecular Names Fran Tuttle to Its Board of Trustees
10. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
11. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...PRNewswire-FirstCall/-- OnyxPharmaceuticals,Inc.(...twoinvestoreventsinDecember: ,, ASHBriefing ..., Principalinvestigatorswilldiscussdatapresenta...orymultiplemyeloma,asfeaturedatthe51stAmericanSoci...wOrleans,LA.Theteleconferencewillbeginat9:00a.m.CT...
(Date:11/25/2009)...RNewswire/--Thanksgivingmealswillbedeliveredtoappr...hareathankstoFaithInAction/VolunteerActionforAging...onofSCANHealthPlan.Formorethan17yearstheseorganiza...ThanksgivingmealstoseniorsinneedinLongBeach,Lakewo...ngcities. ,, "Ourwarmholidaymealsaredeliveredto...
(Date:11/25/2009)...swire/--TheBayAreaAirQualityManagementDistrictisis...r Alert forThursday,November26,2009whichbansb...,bothindoorsandoutdoors. ,, "Cold,stillweatherw...ckBroadbent,executiveofficeroftheAirDistrict."We,r...ighborsandfellowcommunitymembersthisThanksgiving,a...
(Date:11/25/2009)... of a statistically significant survival benefit f...en receptor (ER)-positive tumors had high levels o...lpha S118-P), according to a brief communication p... National Cancer Institute . , Approximately 50%...Preclinical studies have shown that ER-alpha S118-...
(Date:11/25/2009)...o short to draw definite conclusions, experts say,...) -- In diabetic patients with blocked coronary ar...mes at one year whether patients undergo bypass su...chers report. , Bypass surgery has been the sta...y artery disease. However, less invasive approache...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
... 4 Acclarent, Inc., the pioneer of Balloon Sinup...f chronic sinusitis, announced today that the U.S....umber 7,500,971, entitled "Devices, Systems and Me...ds for treating a paranasal sinus ostium, such as ...
...Calm; Take Commonsense Steps to Prevent Spreading ... G. Rendell today announced Pennsylvania,s first l...ar-old man from Montgomery County. , , "Now that...spread of the flu," said Governor Rendell. "Our De...
... Identifying one of the processes that plays a ro...on could one day lead to better vaccines and possi...earchers at Baylor College of Medicine and Texas C...sor of pathology at BCM, along with his research t...
... The American Society for Aesthetic Plastic Surge...inners , New York, NY (Vo... magazine, CNN and ABC News 20/20 are among winner...from over 125 entries, this year,s winners will be...
... The evolution of liposuction will be discussed b...rican Society for Aesthetic Plastic Surgery (ASAPS...ention Center May 2-7, 2009. , ...iety for Aesthetic Plastic Surgery (ASAPS), being ...
...esterol, so study suggests better screening for hy...ews) -- While untreated hypertension in any child ...ous enlargement or thickening of one chamber of th...ents under age 21, researchers from Johns Hopkins ...
Other Medicine News:Health News:Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies 2Health News:Governor Rendell Announces Pennsylvania's First Confirmed Case of 2009 A/H1N1 Flu 2Health News:Governor Rendell Announces Pennsylvania's First Confirmed Case of 2009 A/H1N1 Flu 3Health News:Process controlling T cell growth and production identified 2Health News:Aesthetic Society Awards Journalists' Commitment To Patient Education 2Health News:Aesthetic Society Awards Journalists' Commitment To Patient Education 3Health News:Liposuction Turns 20 2Health News:Liposuction Turns 20 3Health News:Liposuction Turns 20 4Health News:Black Youths With High BP May Face Elevated Heart Risks 2
(Date:11/25/2009)...ire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedi...mallydisruptivesurgicaltreatmentsforthespine,annou...ember30,2009,at5:30p.m.ET/2:30p.m.PT.Theconference...tfortheCompany,sproductsandwillincludecommentsfrom....Thedial-innumbersare1-877-407-4018fordomesticcall...
(Date:11/25/2009)...JOHANNESBURG,November25/PRNewswire/--,iThembaPharm...edtoday,thattheyhavesignedacollaborativeagreementt...s,sworldclasscomputationalchemistryandleaddiscover...ontoprovidemedicinaland,syntheticchemistrysupportt...ntnetwork.iThembaPharmaceuticalsandPyxisDiscovery,...
(Date:11/24/2009)...swire/-- ,, WHAT:RomHoubens,aBelgianmanthoughtt...asactuallyfullyconsciousandawakeduringthattimeandw...xEyeMaxwasfeaturedinthesegmenttoillustratehowpeopl...ommunication. ,, WHEN:GoodMorningAmerica-- Tues...h.com ,, WHO:RomHoubenswasanengineeringstud...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 1GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 2GenVaults GenSolve 28TM 29 Reagents Enable State of the Art Genomic Analysis of Dried Blood Spots 53720 3Article Now Available 3A Are Special Orders Draining Your Budgets 3F 53715 1Article Now Available 3A Are Special Orders Draining Your Budgets 3F 53715 2Article Now Available 3A Are Special Orders Draining Your Budgets 3F 53715 3Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 1Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 2Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 3Ceregene Receives Additional Grant From Michael J Fox Foundation to Expand Long Term Testing of CERE 120 Patients 13382 4
...ONDON, Oct. 23 Morria Biopharmaceuticals Plc, a,b...t of novel,anti-inflammatory drugs, today announce...RX-4 in 16 patients suffering from allergic rhinit...le blind clinical trial is the,first of two module...y in,AR. MRX-4 is nasally administered as a single...
...ASHINGTON, Oct. 22 Today, the American,Society of...ical Oncology,(ASCO) have released an updated join...ng agents (ESAs), a class of drugs that stimulate,...o treat,chemotherapy-related anemia., "One goal o...e most,up-to-date evidence from high-quality studi...
Other Medicine Technology:Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis 2ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 2ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 3
Medic 6 Defibrillator
Ring with Knob Folding Silicone Pessary
Hodge Silicone Folding Pessary Manually Shapeable
Incontinence Ring Silicone Flexible Pessary
Medicine Products: